Washington University, Saint-Louis, MO
Previous: PhD at Ginestier/Charafe lab, CRCM, France
rdcu.be/ecaao
🧬 Victim: CSCs
🔪 Weapon: Nifuroxazide
🎯 Mode: DNA crosslinks + STAT3 block
🧬 Scene: PARPi-resistant breast cancer
From the Charafe/Ginestier team @CRCM
🔗 pubmed.ncbi.nlm.nih.gov/40038300/
✍️ by @celiarouault.bsky.social
🔗 communities.springernature.com/posts/unveil...
🧬 Victim: CSCs
🔪 Weapon: Nifuroxazide
🎯 Mode: DNA crosslinks + STAT3 block
🧬 Scene: PARPi-resistant breast cancer
From the Charafe/Ginestier team @CRCM
🔗 pubmed.ncbi.nlm.nih.gov/40038300/
✍️ by @celiarouault.bsky.social
🔗 communities.springernature.com/posts/unveil...
Discover the parallel between our article: Inhibition of the STAT3/Fanconi anemia axis is synthetic lethal with PARP inhibition in breast cancer and police enquiry communities.springernature.com/posts/unveil... @cginestier.bsky.social
Discover the parallel between our article: Inhibition of the STAT3/Fanconi anemia axis is synthetic lethal with PARP inhibition in breast cancer and police enquiry communities.springernature.com/posts/unveil... @cginestier.bsky.social
www.nature.com/articles/s41...
www.nature.com/articles/s41...
rdcu.be/ecaao
rdcu.be/ecaao
www.cell.com/trends/genet...
www.cell.com/trends/genet...